GeneNews to Host IDL Business Update Conference Call on May 18, 2017

TORONTO, May 15, 2017 /CNW/ - In response to investor and media inquiries received about the operations and partnership activities at its Virginia-based Innovative Diagnostic Laboratory ("IDL") clinical reference lab, GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") today announced that its Chairman and CEO, James Howard-Tripp, will host a conference call at 4:30 p.m. ET on Thursday, May 18, 2017 to discuss IDL's business.

IDL Business Update Conference Call Details:

Date:        Thursday, May 18, 2017

Time:        4:30 p.m. ET

Live Call:  (888) 231-8191 (Canada and the United States)

                 (647) 427-7450 (International)

                 Conference ID: 24600536

Replay:     (855) 859-2056 (Canada and the United States)

                 (416) 849-0833 (International)

                 Password: 24600536


The call will also be broadcast live and archived on the Company's website at in the Investor's section.

About GeneNews

GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Our mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health out-comes through the early diagnosis of disease.  Our Richmond, Virginia-based Innovative Diagnostic Laboratory clinical reference lab specializes in traditional and advanced clinical evidence-based blood testing that helps find, understand, and address cancer risk in patient populations. Currently, IDL offers risk assessment blood tests for four prevalent cancer types - colon, lung, prostate and breast. GeneNews' common shares trade on the Toronto Stock Exchange under the symbol 'GEN'.  More information on GeneNews and IDL can be found at and, respectively.

Forward-Looking Statements

This press release contains forward-looking statements identified by words such as "expects", "will" and similar expressions, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company's actual events to differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law. 

SOURCE GeneNews Limited

For further information: Company Contact: James R. Howard-Tripp, Chairman & CEO, Office: (905) 209-2030,; Investor & Media Relations: Stephen Kilmer, Kilmer Lucas Inc., Office: (647) 872-4849,


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890